| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.22568 |
| P698 | PubMed publication ID | 17469095 |
| P50 | author | Ronald H. W. M. Derksen | Q73744763 |
| Marianne C. Verhaar | Q40340965 | ||
| P2093 | author name string | Hein A Koomans | |
| Peter E Westerweel | |||
| Remco K M A C Luyten | |||
| P2860 | cites work | Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 |
| Vascular stiffness in women with systemic lupus erythematosus | Q43576508 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study | Q43846699 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| P433 | issue | 5 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| systemic lupus erythematosus | Q1485 | ||
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 1384-1396 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus | |
| P478 | volume | 56 |
| Q63694272 | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol |
| Q40171187 | A Randomized, Double-blind, Placebo-controlled Clinical Trial Examining the Effects of Green Tea Extract on Systemic Lupus Erythematosus Disease Activity and Quality of Life. |
| Q84966324 | Antihyperlipidemic and antitumor effects of chickpea albumin hydrolysate |
| Q39028912 | Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis |
| Q37160132 | Association between depression and coronary artery calcification in women with systemic lupus erythematosus |
| Q52852275 | Atherosclerosis in primary antiphospholipid syndrome. |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q83233981 | Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification |
| Q36468887 | Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis |
| Q43152580 | Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease |
| Q40263037 | Down-regulation of nectin-4 inhibits apoptosis in systemic lupus erythematous (SLE) through targeting Bcl-2/Bax pathway |
| Q33633643 | Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors |
| Q37478067 | Endothelial progenitor cell dysfunction in rheumatic disease |
| Q37670939 | High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy |
| Q43197413 | High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome |
| Q36411062 | Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis |
| Q33727314 | Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort |
| Q34109302 | Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation. |
| Q34506731 | Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus |
| Q89099489 | Microparticles (CD146) and Arterial Stiffness Versus Carotid Intima Media Thickness as an Early Predictors of Vascular Affection in Systemic Lupus Patients |
| Q33389669 | Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus |
| Q34101743 | Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators |
| Q83240616 | Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus |
| Q33387473 | Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study |
| Q37406201 | Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort |
| Q37221927 | Proximal aortic stiffness is increased in systemic lupus erythematosus activity in children and adolescents |
| Q38010014 | Recent progress in the treatment of lupus nephritis |
| Q47260542 | Relationship between Neutrophil-to-Lymphocyte Ratio and Pulse Wave Velocity in Young Patients with Systemic Lupus Erythematosus. |
| Q47148225 | Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification |
| Q47158536 | Resveratrol Role in Autoimmune Disease-A Mini-Review. |
| Q37197627 | Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux |
| Q36709328 | Semiquantified noncalcified coronary plaque in systemic lupus erythematosus |
| Q46934492 | Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis |
| Q48073758 | Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life |
| Q37369679 | The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases? |
| Q99630439 | The Use of Risk Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-society Cholesterol Guidelines |
| Q89743939 | The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk |
| Q28486062 | The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus |
| Q33575750 | The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice. |
| Q48260311 | The quality of life of patients with lupus erythematosus influences cardiovascular capacity in 6-minute walk test |
| Q37113440 | Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus |
| Q34478798 | Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy |
| Q34478814 | Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy |
Search more.